Icelandic company Kerecis, which has developed the use of fish skin and fatty acids in cellular therapy and tissue regeneration and protection, has received the Nordic Scaleup Award for 2023.
‘The company is a prime example of a scaleup that is built on the heritage of Iceland, utilizes a by-product from fish processing to create a high-value medical product and, due to a limited home market and talent base, has been forced to be creative in their hiring and go-to-market strategy from day one,’ said Svein Berg, managing director of Nordic Innovation and the chairman of the Nordic Scaleup Award jury.
‘As an innovative and growing biotech company, it has the ability to deliver enduring impact.’
The Nordic Scaleup Award recognizes high growth companies that demonstrate best-of-class business performance in growing their companies in impactful and sustainable ways, and in promoting diverse and inclusive company cultures. The award is organised by Nordic Innovation, which is a part of the formal governmental cooperation among the Nordic countries.
‘Our fast growth is driven by an incredible team of employees that have a very clear purpose of utilising our fish-skin technology and digital platform to improve the lives of patients and help prevent amputations and tissue damage,’ said Kerecis founder and CEO Fertram Sigurjónsson.
‘A big part of our scaling success comes from the United States where Nordic companies are considered trustworthy business partners, which connects us even more to this award.’
